Sarissa Consulting LLC Chemo Centryx, Inc. Transaction History
Sarissa Consulting LLC
- $96.9 Million
- Q3 2022
A detailed history of Sarissa Consulting LLC transactions in Chemo Centryx, Inc. stock. As of the latest transaction made, Sarissa Consulting LLC holds 8,000 shares of CCXI stock, worth $0. This represents 0.43% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$0% of portfolio
0.43%Shares
1 transactions
Others Institutions Holding CCXI
# of Institutions
6Shares Held
66.3KCall Options Held
0Put Options Held
0-
S. Muoio & Co. LLC New York, NY58KShares$03.96% of portfolio
-
Wipfli Financial Advisors Llc,216Shares$00.0% of portfolio
-
Exane Derivatives92Shares$00.0% of portfolio
-
Four Thought Financial, LLC Venice, FL24Shares$00.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$00.0% of portfolio
About ChemoCentryx, Inc.
- Ticker CCXI
- Exchange NASDAQ
- Shares Outstandng 71,919,696
- Market Cap $3.68M
- Description
- ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...